XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (5341)	1/13/1998 9:19:00 PM
From: Robert K.	Read Replies (1) of 17367

Xoma no longer has right to cd20 royalties, as I have been told. Also I hear cacaitos analysis is good job. Lastly meningiococcemia has accrued almost 140 and will keep on accruing probably thru april when dsmb will probably meet. We may see 160 to 190 by then and that might be significant. bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next